Literature DB >> 12642751

The fluctuation of serum levels of aminotransferase in patients with nonalcoholic steatohepatitis.

Süleyman H Ipekci, Metin Basaranoglu, Abdullah Sonsuz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12642751     DOI： 10.1097/00004836-200304000-00021

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN： 0192-0790            Impact factor:   3.062


× No keyword cloud information.
  11 in total

1.  The effects of rosiglitazone, metformin, and diet with exercise in nonalcoholic fatty liver disease.

Authors:  Filiz Akyüz; Kadir Demir; Sadakat Ozdil; Nevzat Aksoy; Sule Poturoğlu; Duygu Ibrişim; Sabahattin Kaymakoğlu; Fatih Beşişik; Güngör Boztaş; Yilmaz Cakaloğlu; Zeynel Mungan; Uğur Cevikbaş; Atilla Okten
Journal:  Dig Dis Sci       Date:  2007-04-11       Impact factor: 3.199

2.  Does vitamin D improve liver enzymes, oxidative stress, and inflammatory biomarkers in adults with non-alcoholic fatty liver disease? A randomized clinical trial.

Authors:  Nasrin Sharifi; Reza Amani; Eskandar Hajiani; Bahman Cheraghian
Journal:  Endocrine       Date:  2014-06-27       Impact factor: 3.633

Review 3.  Drug metabolism alterations in nonalcoholic fatty liver disease.

Authors:  Matthew D Merrell; Nathan J Cherrington
Journal:  Drug Metab Rev       Date:  2011-05-25       Impact factor: 4.518

4.  Altered regulation of hepatic efflux transporters disrupts acetaminophen disposition in pediatric nonalcoholic steatohepatitis.

Authors:  Mark J Canet; Matthew D Merrell; Rhiannon N Hardwick; Amy M Bataille; Sarah N Campion; Daniel W Ferreira; Stavra A Xanthakos; Jose E Manautou; H Hesham A-Kader; Robert P Erickson; Nathan J Cherrington
Journal:  Drug Metab Dispos       Date:  2015-03-18       Impact factor: 3.922

Review 5.  Nonalcoholic fatty liver disease.

Authors:  Leon A Adams; Paul Angulo; Keith D Lindor
Journal:  CMAJ       Date:  2005-03-29       Impact factor: 8.262

6.  Nonalcoholic fatty liver disease increases risk of death among patients with diabetes: a community-based cohort study.

Authors:  Leon A Adams; Scott Harmsen; Jennifer L St Sauver; Phunchai Charatcharoenwitthaya; Felicity B Enders; Terry Therneau; Paul Angulo
Journal:  Am J Gastroenterol       Date:  2010-02-09       Impact factor: 10.864

Review 7.  From fatty liver to fibrosis: a tale of "second hit".

Authors:  Metin Basaranoglu; Gökcen Basaranoglu; Hakan Sentürk
Journal:  World J Gastroenterol       Date:  2013-02-28       Impact factor: 5.742

Review 8.  KASL clinical practice guidelines: management of nonalcoholic fatty liver disease.

Authors: 
Journal:  Clin Mol Hepatol       Date:  2013-12-28

9.  The effect of pioglitazone and metformin on liver function tests, insulin resistance, and liver fat content in nonalcoholic Fatty liver disease: a randomized double blinded clinical trial.

Authors:  Mohsen Razavizade; Raika Jamali; Abbas Arj; Seyyed Mohammad Matini; Alireza Moraveji; Effat Taherkhani
Journal:  Hepat Mon       Date:  2013-05-21       Impact factor: 0.660

10.  Prediction of Nonalcoholic Fatty Liver Disease Via a Novel Panel of Serum Adipokines.

Authors:  Raika Jamali; Abbas Arj; Mohsen Razavizade; Mohammad Hossein Aarabi
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.